CAM
Cormorant Asset Management’s Atea Pharmaceuticals AVIR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,547,181
| Closed | -$5.79M | – | 53 |
|
|
2023
Q2 | $5.79M | Hold |
1,547,181
| – | – | 0.32% | 47 |
|
|
2023
Q1 | $5.18M | Hold |
1,547,181
| – | – | 0.34% | 46 |
|
|
2022
Q4 | $7.44M | Hold |
1,547,181
| – | – | 0.5% | 43 |
|
|
2022
Q3 | $8.8M | Hold |
1,547,181
| – | – | 0.62% | 42 |
|
|
2022
Q2 | $11M | Hold |
1,547,181
| – | – | 0.83% | 37 |
|
|
2022
Q1 | $11.2M | Sell |
1,547,181
-132,261
| -8% | -$955K | 0.86% | 34 |
|
|
2021
Q4 | $15M | Sell |
1,679,442
-3,249,314
| -66% | -$29M | 0.89% | 31 |
|
|
2021
Q3 | $173M | Sell |
4,928,756
-1,482,599
| -23% | -$52M | 7.02% | 3 |
|
|
2021
Q2 | $138M | Hold |
6,411,355
| – | – | 4.68% | 2 |
|
|
2021
Q1 | $396M | Hold |
6,411,355
| – | – | 8.82% | 1 |
|
|
2020
Q4 | $260M | Buy |
+6,411,355
| New | +$260M | 6.18% | 2 |
|